Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Dividends Paid - Common (2016 - 2025)

Conmed's Dividends Paid - Common history spans 14 years, with the latest figure at $6.2 million for Q4 2025.

  • For Q4 2025, Dividends Paid - Common changed 0.23% year-over-year to $6.2 million; the TTM value through Dec 2025 reached $24.7 million, changed 0.39%, while the annual FY2025 figure was $24.7 million, 0.39% changed from the prior year.
  • Dividends Paid - Common reached $6.2 million in Q4 2025 per CNMD's latest filing, roughly flat from $6.2 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $6.2 million in Q4 2025 to a low of $5.8 million in Q1 2021.
  • Average Dividends Paid - Common over 5 years is $6.1 million, with a median of $6.1 million recorded in 2023.
  • Peak YoY movement for Dividends Paid - Common: increased 4.49% in 2022, then increased 0.23% in 2025.
  • A 5-year view of Dividends Paid - Common shows it stood at $5.8 million in 2021, then grew by 4.4% to $6.1 million in 2022, then increased by 0.89% to $6.1 million in 2023, then increased by 0.46% to $6.2 million in 2024, then increased by 0.23% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Dividends Paid - Common are $6.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.2 million (Q2 2025).